cabozantinib | Cabozantinib

Keyword	CPC	PCC	Volume	Score	Length of keyword
cabozantinib	1.58	1	5950	15	12

Keyword	CPC	PCC	Volume	Score
cabozantinib	0.36	0.7	5390	3
cabozantinib package insert	1.15	1	7394	65
cabozantinib side effects	0.95	0.5	9686	57
cabozantinib 40 mg	0.61	0.4	5915	61
cabozantinib mechanism of action	0.61	0.3	9674	55
cabozantinib moa	1.93	0.8	8313	80
cabozantinib fda	1.44	0.5	6768	49
cabozantinib fda label	0.41	1	1505	49
cabozantinib spc	0.09	0.7	3731	37
cabozantinib s-malate	0.57	0.2	3218	55
cabozantinib price	1.7	0.8	7866	25
cabozantinib hcc	1.19	0.8	7036	79
cabozantinibe	0.42	0.5	2777	76
cabozantinib 60 mg	2	0.7	8268	81
cabozantinib pi	0.86	1	5688	74
cabozantinib manufacturer	1.73	0.7	2215	40
cabozantinib nets	1.04	0.7	1145	11
cabozantinib fda approval	0.67	0.3	6549	38
cabozantinib tki	1.93	1	6140	26
cabozantinib rcp	1.4	1	9485	93
cabozantinib fachinfo	0.31	0.9	1672	80
cabozantinib scheda tecnica	0.74	0.2	6209	84
cabozantinib bc cancer	0.75	0.9	3643	41
cabozantinib ficha tecnica	1.47	0.7	1444	29
cabozantinib vs captem	0.45	0.4	5469	23

Search Results related to cabozantinib on Search Engine

Cabozantinib - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Cabozantinib

WEBCabozantinib, sold under the brand names Cometriq and Cabometyx among others, is an anti-cancer medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. [8] [9] It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET.

DA: 47 PA: 50 MOZ Rank: 53

Cabozantinib Uses, Side Effects & Warnings - Drugs.com
drugs.com

https://www.drugs.com/mtm/cabozantinib.html

WEBAug 23, 2022 · What is cabozantinib? Cabometyx is used to treat advanced kidney cancer, sometimes in combination with another medicine called nivolumab. Cabometyx is also used to treat liver cancer in people who have been previously treated with sorafenib. Cabometyx can also be used to treat thyroid cancer in people 12 years and older.

DA: 43 PA: 66 MOZ Rank: 20

CABOMETYX® (cabozantinib) Patient Website
cabometyx.com

https://www.cabometyx.com/

WEBSwelling of your arms, hands, legs, and ankles. Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with CABOMETYX if you have certain side effects. The most common side effects of CABOMETYX include: Tiredness. Decreased appetite. Nausea and vomiting.

DA: 22 PA: 50 MOZ Rank: 83

Cabozantinib (Oral Route) Description and Brand Names - Mayo Clinic
mayoclinic.org

https://www.mayoclinic.org/drugs-supplements/cabozantinib-oral-route/description/drg-20060654

WEBApr 1, 2024 · Cabozantinib capsule is used to treat medullary thyroid cancer that has already spread to different parts of the body. Cabozantinib tablet is used alone to treat advanced kidney cancer. It is also used in combination with nivolumab as first-line treatment for advanced kidney cancer.

DA: 58 PA: 6 MOZ Rank: 55

Cabozantinib: Uses, Interactions, Mechanism of Action
drugbank.com

https://go.drugbank.com/drugs/DB08875

WEBSummary. Cabozantinib is a tyrosine kinase inhibitor used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. Brand Names. Cabometyx, Cometriq. Generic Name. Cabozantinib. DrugBank Accession Number. DB08875. Background.

DA: 72 PA: 16 MOZ Rank: 77

Cabozantinib: MedlinePlus Drug Information
medlineplus.gov

https://medlineplus.gov/druginfo/meds/a616037.html

WEBCabozantinib (Cometriq) is used to treat a certain type of thyroid cancer that is getting worse and that has spread to other parts of the body. Cabozantinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.

DA: 84 PA: 9 MOZ Rank: 23

Cabozantinib-S-Malate - NCI - National Cancer Institute
cancer.gov

https://www.cancer.gov/about-cancer/treatment/drugs/cabozantinib-s-malate

WEBCabozantinib-s-malate is approved to treat: Differentiated thyroid cancer that has spread. It is used in adults and children aged 12 years and older who cannot receive radioactive iodine and whose cancer got worse after VEGF receptor-targeted therapy. This use is approved for the Cabometyx brand of cabozantinib-s-malate.

DA: 31 PA: 95 MOZ Rank: 50

Cabozantinib Oral: Uses, Side Effects, Interactions, Pictures ... - WebMD
webmd.com

https://www.webmd.com/drugs/2/drug-163010/cabozantinib-oral/details

WEBGeneric Name (S): cabozantinib. Uses. Side Effects. Precautions. Interactions. Overdose. Uses. This medication is used to treat various types of cancer (including kidney, thyroid, liver cancer...

DA: 19 PA: 78 MOZ Rank: 80

Cabozantinib | Memorial Sloan Kettering Cancer Center
mskcc.org

https://www.mskcc.org/cancer-care/patient-education/medications/adult/cabozantinib

WEBDec 12, 2022 · Cabozantinib. Adult Medication. This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider. Brand Names: US. Cabometyx; Cometriq (100 MG Daily Dose); Cometriq (140 MG Daily Dose); Cometriq (60 MG Daily …

DA: 18 PA: 46 MOZ Rank: 65

Cabozantinib (thyroid cancer): MedlinePlus Drug Information
medlineplus.gov

https://medlineplus.gov/druginfo/meds/a613015.html

WEBCabozantinib (Cometriq) is used to treat a certain type of thyroid cancer that is getting worse and that has spread to other parts of the body. Cabozantinib (Cometriq) is in a class of medications called tyrosine kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.

DA: 80 PA: 96 MOZ Rank: 89